Metraipolis › archive › dc_dc9b885395da
Glucocorticoid reduction after starting crinecerfont in adult patients with classic CAH: practical perspectives — Europe PMC PMID:41921547
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41921547
- DOI
- 10.1210/clinem/dgag147
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T05:17:22.112Z
- SHA-256 of the archived text
8c667eb3cb0fb85f4a70a7af8ca678b21d0ba0c1c4d33d093b2be9d72ca3d742- Stable URL of this page
https://metraipolis.com/documento/dc_dc9b885395da
How to cite
Glucocorticoid reduction after starting crinecerfont in adult patients with classic CAH: practical perspectives — Europe PMC PMID:41921547 — Europe PMC (en), https://europepmc.org/article/MED/41921547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc9b885395da (Metraipolis archive dc_dc9b885395da, sha256 8c667eb3cb0fb85f4a70a7af8ca678b21d0ba0c1c4d33d093b2be9d72ca3d742)
BibTeX
@misc{dcdc9b885395da,
title = {Glucocorticoid reduction after starting crinecerfont in adult patients with classic CAH: practical perspectives — Europe PMC PMID:41921547},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41921547},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc9b885395da; sha256 8c667eb3cb0fb85f4a70a7af8ca678b21d0ba0c1c4d33d093b2be9d72ca3d742},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41921547. Agents can read the archived copy with the MCP tool read_document.